Skip to main content

Clinical Presentation of Restenosis

  • Chapter
Essentials of Restenosis

Abstract

Coronary artery disease remains a major cause of mortality and morbidity. Unstable angina and non-Q-wave myocardial infarction (MI) account for approx 2–2.5 million hospitalizations worldwide (1). Furthermore, unstable angina is associated with a high risk of MI or death if treated inadequately (2). Advances in clinical therapeutics and the introduction of percutaneous coronary therapy by Grüntzig and coworkers in the late 1970s have revolutionalized the way ischemic heart disease is managed in clinical practice (3). Percutaneous coronary intervention (PCI) is now the primary mode of treatment for managing occlusive coronary disease in symptomatic patients. However, the practice of using stand-alone balloon angioplasty has largely been superseded by the addition of stent deployment to improve procedural success and outcome ((4)–(7)). The advent of the stent era and improvements in stent technology has enabled treatment of more complex and difficult coronary lesions, with multivessel stenting and techniques such as direct stenting (8), increasing in frequency.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). J Am Coll Cardiol 2000;36:970–972.

    PubMed  CAS  Google Scholar 

  2. Collinson J, Flather MD, Fox KAA, et al. Clinical outcomes, risk stratification and practice patterns of Unstable angina and myocardial infarction without ST elevation: Prospective Registry of acute ischaemic syndromes in the UK (PRAIS-UK). Eur Heart J 2000;21:1450–1457.

    PubMed  CAS  Google Scholar 

  3. Grüntzig AR, Senning Ä, siegenthaler WE. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med 1979;301:61–68.

    PubMed  Google Scholar 

  4. Sigwart U, Puel J, Mirkovitch V, et al. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Eng J Med 1987;316:701–706.

    CAS  Google Scholar 

  5. Betriu A, Masotti M, Serra A, et al. Randomised comparison of coronary stent implantation and balloon angioplasty in the treatment of de novo coronary artery lesions (START): a four-year follow-up. J Am Coll Cardiol 1999;34:1498–1506.

    PubMed  CAS  Google Scholar 

  6. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon expandable stent implantation with balloon angioplasty in patients with coronary artery disease: the BENESTENT study group. N Eng J Med 1994;331:489–495.

    CAS  Google Scholar 

  7. Fischman DL, Leon MB, Baim DS, et al. A randomised comparison of stent placement and balloon angioplasty in the treatment of coronary artery disease: Stent Restenosis Study Investigators. N Eng J Med 1994;331:496–501.

    CAS  Google Scholar 

  8. Barbato E, Marco J, Wijns W. Direct stenting. Eur Heart J 2003;24:394–403.

    PubMed  Google Scholar 

  9. Mintz GS, Popma JJ, Pichard AD, et al. Arterial remodelling after coronary angioplasty: a serial intravascular ultrasound study. Circulation 1996;94:35–43.

    PubMed  CAS  Google Scholar 

  10. Hoffman R, Mintz GS, Dussaillant GR, et al. Patterns and mechanisms of in-stent restenosis: a serial intravascular ultrasound study. Circulation 1996;94:1247–1254.

    Google Scholar 

  11. Virmani R, Farb A. Pathology of in-stent restenosis. Curr Opin Lipidol 1999;10:499–506.

    PubMed  CAS  Google Scholar 

  12. Guiteras P, Tomas L, Varas C, et al. Five years of angiographic and clinical follow-up after successful percutaneous transluminal coronary angioplasty. Eur Heart J 1989;10(Suppl G):42–48.

    PubMed  Google Scholar 

  13. Kober G, Vallbracht C, Kadel C, et al. Results of repeat angiography up to eight years following percutaneous transluminal angioplasty. Eur Heart J 1989;10(Suppl G):49–53.

    PubMed  Google Scholar 

  14. Mercado N, Boersma E, Wijns W, et al. Clinical and quantitative coronary angiographic predictors of coronary restenosis: a comparative analysis from the balloon-to-stent-era. J Am Coll Cardiol 2001;38:645–652.

    PubMed  CAS  Google Scholar 

  15. Martnez-Elbal L, Ruiz-Nodar JM, Zueco J, et al. Direct coronary stenting versus stenting stenting with balloon predilatation: mmediate and follow-up results of a multicentre, prospective randomised study. The DISCO trial. Eur Heart J 2002;23:633–640.

    Google Scholar 

  16. Mudra H, di Mario C, de Jaegere, et al. Randomised comparison of coronary stent implantation under ultrasound or angiographic guidance to reduce stent restenosis (OPTICUS Study). Circulation 2001;104:1343–1349.

    PubMed  CAS  Google Scholar 

  17. Mehilli J, Kastrati A, Dirschinger J, et al. A randomised trial comparing the hand-mounted JoStent with the premounted Multi-Link Duet stent in patients with coronary artery disease. Catheter Cardiovasc Interv 2001;54:414–419.

    PubMed  CAS  Google Scholar 

  18. Babapulle MN, Eisenberg MJ. Coated stents for the prevention of restenosis: PartI. Circulation 2002;106:2734–2743.

    PubMed  Google Scholar 

  19. Babapulle MN, Eisenberg MJ. Coated stents for the prevention of restenosis: Part II. Circulation 2002;106:2859–2866.

    PubMed  Google Scholar 

  20. Morice MC, Serruys PW, Sousa JE, et al. A randomised comparison of a sirolimus-eluting stent with a standard stent for coronary revascularisation. N Eng J Med 2002;346:1773–1780.

    CAS  Google Scholar 

  21. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Eng J Med 2003;349:1315–1323.

    CAS  Google Scholar 

  22. Schofer J, Schlüter M, Gershlick AH, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial. (E-SERIUS). Lancet 2003;362:1093–1099.

    PubMed  CAS  Google Scholar 

  23. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Eng J Med 2004;350:221–231.

    CAS  Google Scholar 

  24. Serruys PW, Degertekin M, Tanabe Kengo, et al. Vascular responses at proximal and distal edges of paclitaxel-eluting stents: serial intravascular ultrasound analysis from the TAXUS II trial. Circulation 2004;109:627–633.

    PubMed  Google Scholar 

  25. Schampaert E, Cohen EA, Schlüter M, et al. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 2004;43(6):1110–1115.

    PubMed  CAS  Google Scholar 

  26. Gershlick A, de Scheerder I, Chevalier B, et al. Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: (ELUTES Trial). Circulation 2004;109:487–493.

    PubMed  CAS  Google Scholar 

  27. Holmes DR, Jr, Leon MB, Moses JW, et al. Analysis of 1-year clinical outcomes in the SIRIUS trial. A randomised trial of a serolimus-eluting stent versus a standard stent n patients at high risk for coronary restenosis. Circulation 2004;109:634–640.

    PubMed  Google Scholar 

  28. Colombo A, Drzewiecki J, Banning A, et al. for the TAXUS II Study group. Randomised study to assess the effectiveness of slow-and moderate release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 2003;108:788–794.

    PubMed  CAS  Google Scholar 

  29. Nobuyoshi M, Kimura T, Nosaka H, et al. Restenosis after successful percutaneous coronary angioplasty: serial angiographic follow-up of 229 patients. J Am Coll Cardiol 1988;12:616–623.

    PubMed  CAS  Google Scholar 

  30. Serruys PW, Luijten HE, Beatt KJ, et al. Incidence of restenosis after successful coronary angioplasty: a time-related phenomena. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3 and 4 months. Circulation 1988;77:361–371.

    PubMed  CAS  Google Scholar 

  31. Califf RM, Fortin DF, Frid DJ, et al. Restenosis after coronary angioplasty: an overview. J Am Coll Cardiol 1991;17:2B–13B.

    PubMed  CAS  Google Scholar 

  32. Kimura T, Yokoi H, Nakagawa Y, et al. Three-year follow-up after implantation of metallic coronaryartery stents. N Engl J Med 1996;334:561–566.

    PubMed  CAS  Google Scholar 

  33. Hoffmann R, Mintz GS. Coronary in-stent restenosis—predictors, treatment and prevention. Eur Heart J 2000;21:1739–1749.

    PubMed  CAS  Google Scholar 

  34. Kimura T, Abe K, Shizuta S, et al. Long-term clinical and angiographic follow-up after coronary stent placement in native coronary arteries. Circulation 2002;105:2986–2991.

    PubMed  Google Scholar 

  35. Goldberg SL, Loussararian A, De Gregorio J, et al. Predictors of diffuse and aggressive intra-stent restenosis. J Am Coll Cardiol 2001;37:1019–1025.

    PubMed  CAS  Google Scholar 

  36. Brenner DJ, Miller RC, Hall EJ. The radiobiology of intravascular irradiation. Int J Radiat Oncol Biol Phys 1996;36:805–810.

    PubMed  CAS  Google Scholar 

  37. Hernández RA, Macaya C, I?iguez A, et al. Midterm outcome of patients with asymptomatic restenosis after coronary balloon angioplasty. J Am Coll Cardiol 1992;19:1402–1409.

    PubMed  Google Scholar 

  38. Ruygrok PN, Webster MWI, de Valk V, et al. Clinical and angiographic factors associated with asymptomatic restenosis after percutaneous coronary intervention. Circulation 2001;104:2289–2294.

    PubMed  CAS  Google Scholar 

  39. Rogers WJ, Bourassa MG, Andrews TC, et al. Asymptomatic Cardiac Ischaemia Pilot (ACIP) study: outcome at 1 year for patients with asymptomatic cardiac ischaemia randomised to medical therapy or revascularisation. J Am Coll Cardiol 1995;26:594–605.

    PubMed  CAS  Google Scholar 

  40. Popma JJ, van de Berg EK, Dehmer GJ. Long term outcome of patients with asymptomatic restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1988;62:1298–1299.

    PubMed  CAS  Google Scholar 

  41. Pfisterer M, Rickenbacher P, Kiowski W, et al. Silent ischaemia after percutaneous coronary angioplasty: incidence and prognostic significance. J Am Coll Cardiol 1993;22:1446–1454.

    PubMed  CAS  Google Scholar 

  42. Cottin Y, Rezaizedah K, Touzery C, et al. Long-term prognostic value of 201Tl single-photon emission computed tomographic myocardial perfusion imaging after coronary stenting. Am Heart J 2001;141:999–1006.

    PubMed  CAS  Google Scholar 

  43. Zellweger MJ, Weinbacher M, Zutter AW, et al. Long-term outcome of patients with silent versus symptomatic ischaemia six months after percutaneous coronary intervention and stenting. J Am Coll Cardiol 2003;42:33–40.

    PubMed  Google Scholar 

  44. Rupprecht HJ, Espinola-Klein C, Erbel R, et al. Impact of routine angiographic follow-up after angioplasty. Am Heart J 1998;136:613–619.

    PubMed  CAS  Google Scholar 

  45. Ruygrok PN, Melkert R, Morel M-AM, et al. Does angiography six months after coronary intervention influence management and outcome? J Am Coll Cardiol 1999;34:1507–1511.

    PubMed  CAS  Google Scholar 

  46. Hermiller JB, Fry ET, Peters TF, et al. Late coronary artery stenosis regression within the Gianturco Roubin intracoronary stent. Am J Cardiol 1996;77:247–251.

    PubMed  CAS  Google Scholar 

  47. Ormiston JA, Stewart FM, Roche AHG, et al. Late regression of the dilated site after coronary angioplasty. Circulation 1997;96:468–474.

    PubMed  CAS  Google Scholar 

  48. Asakura M, Ueda Y, Nanto S, et al. Remodeling of in-stent neointima, which became thinner and transparent over 3 years. Serial angiographic and angioscopic follow-up. Circulation 1998;97:2003–2006.

    PubMed  CAS  Google Scholar 

  49. Holmes DR, Jr, Vliestra RE, Smith HC, et al. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung and Blood Institute. Am J Cardiol 1984;53:77C–81C.

    PubMed  Google Scholar 

  50. Suresh CG, Grant SCD, Henderson RA, et al. Late symptom recurrence after successful coronary angioplasty: angiographic outcome. Int J Cardiol 1993;42:257–262.

    PubMed  CAS  Google Scholar 

  51. Mata LA, Bosch X, David PR, et al. Clinical and angiographic assessment 6 months after double vessel percutaneous coronary angioplasty. J Am Coll Cardiol 1985;6:1239–1244.

    PubMed  CAS  Google Scholar 

  52. Gruentzig AR, King SB III, Schlumpf M, et al. Long-term follow-up after percutaneous transluminal coronary angioplasty. The early Zurich experience. N Eng J Med 1987;316:1127–1132.

    CAS  Google Scholar 

  53. Kent KM, Bentivoglio LG, Block PC, et al. Long-term efficacy of percutaneous transluminal coronary angioplasty (PTCA): report from the National Heart, Lung and Blood Institute PTCA Registry. Am J Cardiol 1984;53:27C–31C.

    PubMed  CAS  Google Scholar 

  54. Serruys PW, Strauss BH, Beatt KJ, et al. Angiographic follow-up after placement of a self expanding coronary artery stent. N Eng J Med 1991;324:13–17.

    CAS  Google Scholar 

  55. Schatz RA, Baim DS, Leon M, et al. Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicentre study. Circulation 1991;83:148–161.

    PubMed  CAS  Google Scholar 

  56. Walters DL, Harding SA, Walsh CR, et al. Acute coronary syndrome is a common clinical presentation of in-stent restenosis. Am J Cardiol 2002;89:491–494.

    PubMed  Google Scholar 

  57. Miller JM, Ohman EM, Moliterno DJ, Califf RM. Restenosis the clinical issues. In: Topol EJ, ed. Textbook of Interventional Cardiology, 3rd ed. WB Saunders, Philadelphia, PA, 1999, pp. 379–415.

    Google Scholar 

  58. Bossi I, Klersy C, Black AJ, et al. In-stent restenosis: lont-term outcome and predictors of subsequent target lesion revascularisation after repeat ballon angioplasty. J Am Coll Cardiol 2000;35:1569–1576.

    PubMed  CAS  Google Scholar 

  59. Cohen DJ, Doucet M, Cutlip DE, et al. Impact of smoking on clinical and angiographic restenosis after percutaneous coronary intervention. Another smoker’s paradox? Circulation 2001;104:773–778.

    PubMed  CAS  Google Scholar 

  60. Hasdai D, Garratt KN, Grill DE, et al. Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization. N Eng J Med 1997;336:755–761.

    CAS  Google Scholar 

  61. Ellis SG, Tamai H, Nobuyoshi M, et al. Contemporary percutaneous treatment of unprotected left main coronary stenosis: initial results from a multicentre registry analysis, 1994–1996. Circulation 1997;96:3867–3872.

    PubMed  CAS  Google Scholar 

  62. Lemos PA, Saia F, Ligthart JMR, et al. Coronary Restenosis after sirolimus-eluting stent implantation. Morphological description and mechanistic analysis from a consecutive series of cases. Circulation 2003;108:257–260.

    PubMed  Google Scholar 

  63. Honda Y, Fitzgerald PJ. Stent thrombosis: an issue revisited in a changing world. Circulation 2003;108:2–5.

    PubMed  Google Scholar 

  64. Haude M, Erbel R, Issa H, et al. Subacute thrombotic complications after intracoronary implantation of Palmaz-Schatz stents. Am Heart J 1993;126:15–22.

    PubMed  CAS  Google Scholar 

  65. Malenka DJ, O’Rourke D, Miller MA, et al. Cause of in-hospital death in 13,232 consecutive patients undergoing percutaneous transluminal coronary angioplasty. Am Heart J 1999;137:632–638.

    PubMed  CAS  Google Scholar 

  66. Orford JL, Lennon R, Melby S, et al. Frequency and correlates of coronary stent thrombosis in the modern era. Analysis of a single centre registry. J Am Coll Cardiol 2002;40:1567–1572.

    PubMed  Google Scholar 

  67. Farb A, Burke AP, Kolodgie FD, et al. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 2003;108:1701–1706.

    PubMed  Google Scholar 

  68. Dadenberg HD, Lotan C, Hasin Y, et al. Acute myocardial infarction—a late complication of intracoronary stent placement. Clin Cardiol 2000;23:376–378.

    Google Scholar 

  69. Heller LI, Shemwell KC, Hug K. Late stent thrombosis in the absence of prior intracoronary brachytherapy. Catheter Cardiovasc Interv 2001;53:23–28.

    PubMed  CAS  Google Scholar 

  70. Park SJ, Shim WH, Ho DS, et al. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Eng J Med 2003;348:1537–1545.

    CAS  Google Scholar 

  71. Kataoka T, Grube E, Honda Y, et al. 7-Hexanoyltaxol-eluting stent for prevention of neointimal growth: an intravascular ultrasound analysis from the Study to Compare Restenosis rate between QueST and QuaDS-QP2 (SCORE). Circulation 2002;106:1788–1793.

    PubMed  CAS  Google Scholar 

  72. Stein B, Weintroub WS, Gebhart SP, et al. Influence of diabetes mellitus on early and late outcomes after percutaneous transluminal coronary angioplasty. Circulation 1995;91:979–989.

    PubMed  CAS  Google Scholar 

  73. Kornowski R, Mintz GS, Kent KM, et al. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia: a serial intravascular ultrasound study. Circulation 1997;95:1366–1369.

    PubMed  CAS  Google Scholar 

  74. Abizaid A, Kornowski R, Mintz GS, et al. The influence of diabetes mellitus on acute and late outcomes following coronary stent implantation. J Am Coll Cardiol 1998;32:584–589.

    PubMed  CAS  Google Scholar 

  75. Elezi S, Kastrati A, Pache J, et al. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol 1998;32:1866–1873.

    PubMed  CAS  Google Scholar 

  76. Van Belle E, Perie M, Braune D, et al. Effects coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularisation in diabetic patients. J Am Coll Cardiol 2002;40:410–417.

    PubMed  Google Scholar 

  77. West NEJ, Ruygrok PN, Disco CMC, et al. Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients. Circulation 2004;109:867–873.

    PubMed  Google Scholar 

  78. Mathew V, Gersh BJ, Williams BA, et al. Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the prevention of restenosis with tranilast and its outcomes (PRESTO) trial. Circulation 2004;109:476–480.

    PubMed  Google Scholar 

  79. Smith SC, Dove JT, Jacobs AK, et al. ACC/AHA guidelines for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 2001;37(8):2215–2239.

    PubMed  Google Scholar 

  80. Mintz GS, Hoffmann R, Mehran R, et al. In-stent restenosis: the Washington Hospital Center experience. Am J Cardiol 1998;81(7A):7E–13E.

    PubMed  CAS  Google Scholar 

  81. Lowe HC, Oesterle SN, Khachigian LM. Coronary in-stent restenosis: current status and future strategies. J Am Coll Cardiol 2002;39:183–193.

    PubMed  Google Scholar 

  82. Mittal S, Weiss DL, Hirshfeld JWJ, et al. Comparison of outcome after stenting for de novo versus restenotic narrowings in native coronary arteries. Am J Cardiol 1997;80:711–715.

    PubMed  CAS  Google Scholar 

  83. Holmes DR, Schwartz RS, Webster MWI, et al. Coronary restenosis: what have we learned from angiography? J Am Coll Cardiol 1991;17:14B–22B.

    PubMed  Google Scholar 

  84. Khan JK, Rutherford BD, McConahay DR, et al. Short-and long-term outcome of percutaneous transluminal coronary angioplasty in chronic dialysis patients. Am Heart J 1990;119:484–489.

    Google Scholar 

  85. Schoebel FC, Gradaus F, Ivens K, et al. Restenosis after elective coronary balloon angioplasty in patients with end-stage renal disease: a case control study using quantitative coronary angiography. Heart 1997;78:337–442.

    PubMed  CAS  Google Scholar 

  86. Koster R, Vieluf D, Kiehn M, et al. Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. Lancet 2000;356:1895–1897.

    PubMed  CAS  Google Scholar 

  87. Kastrati A, Schömig A, Seyfarth M, et al. PIA polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement. Circulation 1999;99:1005–1010.

    PubMed  CAS  Google Scholar 

  88. Ribichini F, Steffenino G, Dellavalle A, et al. Plasma activity and insertion/deletion polymorphism of angiotensin I-converting enzyme. Circulation 1998;97:147–154.

    PubMed  CAS  Google Scholar 

  89. Jørgensen E, Kelbaek H, Helqvist S, et al. Predictors of coronary in-stent restenosis: importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors. J Am Coll Cardiol 2001;38:1434–1439.

    PubMed  Google Scholar 

  90. Fukuda D, Shimada K, Tanaka A, et al. Circulating monocytes and in-stent neointima after coronary stent implantation. J Am Coll Cardiol 2004;43:18–23.

    PubMed  Google Scholar 

  91. Cipollone F, Marini M, Fazia M, et al. Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Arterioscler Thromb Vasc Biol 2001;21:327–334.

    PubMed  CAS  Google Scholar 

  92. Hokimoto S, Ogawa H, Saito T, et al. Increased plasma antigen levels of monocyte chemoattractant protein-1 in patients with restenosis after percutaneous transluminal coronary angioplasty. Jpn Circ J 2000;64:831–834.

    PubMed  CAS  Google Scholar 

  93. Tutar E, Ozcan M, Kilickap M, et al. Elevated whole-blood tissue factor procoagulant activity as a marker of restenosis after percutaneous transluminal coronary angioplasty and stent implantation. Circulation 2003;108:1581–1584.

    PubMed  CAS  Google Scholar 

  94. Kojoglanian SA, Jorgensen MB, Wolde-Tsadik G, et al. Restenosis in intervened coronaries with hyperhomocysteinemia (RICH). Am Heart J 2003;146:1077–1081.

    PubMed  CAS  Google Scholar 

  95. Bauters C, Hubert E, Prat A, et al. Predictors of restenosis after coronary stent implantation. J Am Coll Cardiol 1998;31:1291–1298.

    PubMed  CAS  Google Scholar 

  96. Marie PY, Danchin N, Karcher G, et al. Usefulness of exercise SPECT-thallium o detect asymptomatic restenosis in patients who had angina before coronary angioplasty. Am Heart J 1993;126:571–577.

    PubMed  CAS  Google Scholar 

  97. Giedd KN, Bergmann SR. Myocardial perfusion imaging following percutaneous coronary intervention. The importance of restenosis, disease progression and directed reintervention. J Am Coll Cardiol 2004;43:328–336.

    PubMed  Google Scholar 

  98. Hecht HS, Shaw RE, Chin HL, et al. Silent ischaemia after coronary angioplasty: evaluation of restenosis and extent of ischaemia in asymptomatic patients by tomographic thallium-201 exercise imaging and comparison with symptomatic patients. J Am Coll Cardiol 1991;17:670–677.

    PubMed  CAS  Google Scholar 

  99. Legrand V, Raskinet B, Laarman G, et al. Diagnostic value of exercise electrocardiography and angina after coronary artery stenting. Am Heart J 1997;133:240–248.

    PubMed  CAS  Google Scholar 

  100. Moussa I, Mario CD, Reimers B, et al. Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: frequency, predictors and clinical outcome. J Am Coll Cardiol 1997;29:6–12.

    PubMed  CAS  Google Scholar 

  101. Silva JA, Ramee SR, White CJ, et al. Primary stenting acute myocardial infarction: influence of diabetes mellitus in angiographic results and clinical outcome. Am Heart J 1999;138:446–455.

    PubMed  CAS  Google Scholar 

  102. Cutlip DE, Baim DS, Kalon KL, et al. Stent thrombosis in the modern era: a pooled analysis of multicentre coronary stent clinical trials. Circulation 2001;103:1967–1971.

    PubMed  CAS  Google Scholar 

  103. Cheneau E, Leborgne L, Mintz GS, et al. Predictors of subacute stent thrombosis: Results of a systematic intravascular ultrasound study. Circulation 2003;108:43–47.

    PubMed  Google Scholar 

  104. Schuhlen H, Kastrati A, Dirschinger J, et al. Intracoronary stenting and risk of major adverse cardiac events during the first month. Circulation 1998;98:104–111.

    PubMed  CAS  Google Scholar 

  105. Uren NG, Schwarzacher SP, Metz JA, et al. Predictors and outcomes of stent thrombosis: an intravascular ultrasound registry. Eur Heart J 2002;23:124–132.

    PubMed  Google Scholar 

  106. Karrillon GJ, Morice MC, Benveniste E, et al. Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy: 30-day clinical outcome of the French Multicentre Registry. Circulation 1996;94:1519–1527.

    PubMed  CAS  Google Scholar 

  107. Nakamura S, Colombo A, Gaglione A, et al. Intracoronary ultrasound observations during stent implantation. Circulation 1994;89:2026–2034.

    PubMed  CAS  Google Scholar 

  108. Werner GS, Gastmann O, Ferrari M, et al. Risk factors for acute and subacute stent thrombosis after high-pressure stent implantation: a study by intracoronary ultrasound. Am Heart J 1998;135:300–309.

    PubMed  CAS  Google Scholar 

  109. De Servi S, Repetto S, Klugmann S, et al. Stent thrombosis: incidence and related factors in the RISE Registry (Registro Impianto Stent Endocoronarico). Catheter Cardiovasc Interv 1999;46:13–18.

    PubMed  Google Scholar 

  110. Versaci F, Gaspardone A, Tomai F, et al. A comparison of coronary artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery. N Eng J Med 1997;336:817–822.

    CAS  Google Scholar 

  111. Levine S, Ewels CJ, Rosing DR, et al. Coronary angioplasty: clinical and angiographic follow-up. Am J Cardiol 1985;55:673–676.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Humana Press Inc.

About this chapter

Cite this chapter

Manoharan, G., Davidavicius, G., Wijns, W. (2007). Clinical Presentation of Restenosis. In: Duckers, H.J., Nabel, E.G., Serruys, P.W. (eds) Essentials of Restenosis. Contemporary Cardiology. Humana Press. https://doi.org/10.1007/978-1-59745-001-0_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-001-0_3

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-491-3

  • Online ISBN: 978-1-59745-001-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics